- Canopy recorded a quarterly revenue of $21.7 million, the highest ever reported in Canadian cannabis sector.
- Quarterly sales of $1 million Germany , all from domestic Canadian production.
- Raised$245 million in landmark deal with Fortune 500 company Constellation Brands and subsequent $201 million bought deal financing including the first co-led by a major bank, BMO Capital Markets
Only cannabis company to secure multi-year supply agreements with four provincial entities; multi-year commitments from Canopy totaling up to 25,000 kilograms per year. - Registered patient growth of 138% and revenue growth of 123%.
- Secured four retail license allocations inNewfoundland and Labrador, locations represent first announced privately owned and operated legal cannabis retail locations in Canada.
- International production licenses announced inDenmark and Jamaica (provisional), bringing number of global licensed facilities to 100
- Approximately$400 million cash on hand to fund domestic and global expansion
Canopy Growth Corp is traded on the TSX under the Ticker Symbol WEED
Financial Highlights
| Q3 2018 | Q2 2018 | % Change | Q3 2017 | % Change | |
| Active registered patients | 69,000 | 63,000 | 10% | 29,000 | 138% |
| Kilograms and kilogram equivalents sold | 2,330 | 2,020 | 15% | 1,245 | 87% |
| Kilograms harvested | 7,961 | 4,167 | 91% | 5,264 | 51% |
| Inventory & Biological Assets (millions) | $108 | $97 | 11% | $56 | 93% |
| Revenues (millions) | $21.7 | $17.6 | 23% | $9.8 | 123% |
| Average selling price per gram | $8.30 | $7.99 | 4% | $7.36 | 13% |
| Cost per gram to point of harvest 1 | $0.59 | $0.72 | -18% | $0.87 | -32% |
| Cost per gram before shipping and fullfillment 1 | $1.03 | $1.25 | -18% | $1.70 | -39% |
| Cash and Cash Equivalents (millions)2 | $238 | $108 | 121% | $93 | 156% |
